Diligence memo · auto-generated · as of July 2, 2026
Elevate Care International Topco LP
Elevate Care International Topco LP looks over-valued against its niche peers and is at-risk on financing cadence.
Businessfiled
Elevate Care International Topco LP operates in Healthtech, based in WASHINGTON.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Elevate Care International Topco LP has raised $98M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $98M on 2023-10-31.
Most recent recorded round closed around 2023-10-31.
Valuation (modeled)modeled
Provath models Elevate Care International Topco LP at approximately $1.0B (range $358M–$1.7B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.07× the median modeled value of Series C Healthtech companies in 2022–2024 (39 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 2.7 yr ago; this sector typically re-raises about every 14 months.
Past due for a raise versus sector cadence — watch for distress or a bridge.
Comparablesmixed
Capital scale ranks ahead of 96% of Healthtech peers (2138 compared).
Modeled value ranks above 97% of those peers.
Closest niche peers: Freedom Dental Funding, LLC, Athelas Inc., Hazel Health, Inc., Health Gorilla, Inc., Employee Health Holdings, LP.
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
Overdue for a raise versus sector norm — distress or bridge risk.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.